About
Articles by Scott
-
The Next Decade Doesn’t Build Itself—Here’s Where We’re Placing Our Chips
The Next Decade Doesn’t Build Itself—Here’s Where We’re Placing Our Chips
Transparency is king and makes us all better. I’m committing to that idea today by sharing the output from our…
4 Comments
Activity
6K followers
-
Scott Maloney shared thisSo close you can taste it. #AnimalHealth #PetsScott Maloney shared thisHospital construction update! We are a few weeks away - Grand Opening is September 21st! 💫😻 #CatsOnly #FelineMedicine #Cats #CatsMatter #CatParents Kristin Wuhrman Scott Maloney Jason Epstein Craig S. Wallace Alley Flood Alex Emerson Courtney Schauer Ellen Carozza LVT, RVT, VTS(CP-Feline) Joshua Stern Mikel Delgado, PhD
-
Scott Maloney posted thisOne of the more interesting things about rapid growth is that it changes the questions faster than it changes the people answering them. At first, most of the work is proving something can exist. You move quickly, make imperfect decisions, compensate for missing resources with effort, and rely heavily on instinct. Then, if things go well, the environment changes. What worked because a few people could carry everything in their heads suddenly needs to become a system. Judgment has to become process, instinct has to become teachable, and decisions once improved by your involvement can eventually live without it. I’ve been thinking about that a lot lately. Growth has a way of exposing which habits were actual strengths and which were simply useful adaptations to being small. The old habits usually worked and that is why you trust them. And that is probably why they are so difficult to outgrow. #Leadership #Entrepreneurship #BusinessGrowth #Strategy #PersonalGrowth
-
Scott Maloney posted thisAnimal health has a strange habit of treating scientific elegance like commercial value. They are not the same thing. Not even close. A beautiful mechanism of action, a clever platform, or a statistically impressive experiment is intellectually satisfying. But biology does not care about pitch decks, and markets care even less. The valuable science is the science that delivers game-changing value in reality: reproducibility, manufacturability, regulatory scrutiny, economics, workflow, and an actual customer willing to pay for the outcome because they immediately see the benefit. That is why some spectacular science becomes a footnote, while comparatively boring science becomes a billion-dollar product. The moat was never just the molecule…it was everything required to make the molecule matter. #AnimalHealth #Biotechnology #LifeSciences #Innovation #Biotechnology #DrugDevelopment #Commercialization
-
Scott Maloney posted thisMost “strategic partnerships” are just two companies agreeing to schedule another call. One company contributes a logo. The other company contributes a logo. Together, they issue a press release about “combining complementary strengths” to “unlock shared value across an evolving ecosystem.” Nobody knows what any of that means, but Marketing found high-resolution versions of both logos, so momentum is clearly building. Then comes the familiar mating ritual. The introductory call. The NDA. The 43-slide capabilities deck. The follow-up call about the introductory call. The formation of a steering committee. And finally, the standing monthly meeting whose agenda gradually deteriorates into “general updates and potential areas of collaboration.” At that point, the partnership has achieved sentience and exists primarily to preserve its own calendar invitations. The problem is not that the people involved are unserious. The problem is that “strategic partnership” has become corporate camouflage for a missing transaction. It allows both companies to announce motion without experiencing movement. Executives can mention the partnership in board presentations. Business development can put it in the pipeline. Marketing can publish the announcement. Entire teams can spend quarters “exploring synergies.” Everyone gets credit for progress, while nobody accepts the career risk of committing money, customers, assets, or an actual deadline. It is organizational dating in which both parties keep saying they are “excited to see where this goes.” Real strategic partnerships require reciprocal exposure. Someone commits capital, customers, distribution, intellectual property, data, capacity, exclusivity, or reputation. The other party commits something equally real. There is an owner, a timetable, a measurable outcome, and some consequence if either side fails to perform. If walking away costs nothing, nobody agreed to much. The test is fairly simple. What is each party contributing that it would genuinely notice losing? Who has the authority to make decisions? What specifically must happen, and by when? What happens if it does not? What is each company willing to stop doing because it chose this partnership instead? If the answers are “access,” “visibility,” “exploration,” “shared learning,” and “continued dialogue,” congratulations. You do not have a strategic partnership. You have networking in a nicer PowerPoint. There is nothing wrong with taking a meeting, building a relationship, or exploring an opportunity. Those are often worthwhile. But calling every pleasant conversation a strategic partnership does not create value. It creates an ever-expanding cemetery of calendar invitations. A strategic partnership begins when both parties commit something scarce and accept the possibility that it might hurt. Then you measure true value. #StrategicPartnerships #BusinessDevelopment #CorporateStrategy #Execution
-
Scott Maloney shared thisWe have a number of postings up as we grow, so check out our most recent. Have a huge impact and a heck of a lot of fun while helping patients. Can’t beat it! CatsOnly Veterinary Services #VetCare #Pets #AnimalHealth
-
Scott Maloney shared thisHere we go! Supporting the community and Humane Colorado is a no-brainer. One of our first events in Denver for CatsOnly Veterinary Services was a raging success. We already knew there was an ocean of cat parents excited to see care for their beloved cats evolve, but this was electric! CatsOnly Veterinary Services opens its doors at the Stanley Marketplace in August. We can’t wait to see you there. #PetCare #Cats #VeterinaryClinic #AnimalHealthScott Maloney shared thisToday we had a blast supporting Humane Colorado at the annual Furry Scurry 5K! Our booth had constant traffic with so many great conversations with Cat Parents and excitement about CatsOnly Veterinary Services coming to Denver! We brought a little fun with us too, DIY catnip bags, stickers, and a first look at what our practice will feel like, designed entirely through the Cat’s lens. Grateful to support Humane Colorado and be part of a community that cares this deeply about Cats and the people who love them. 🧡🐱 Also, we are now in FB and IG! Please follow us! IG: https://lnkd.in/eQC2APaf FB: https://lnkd.in/eyMWccUv Courtney Schauer Kristin Wuhrman Scott Maloney Jason Epstein Craig S. Wallace Ellen Carozza LVT, VTS(CP-Feline) Alex Emerson Joshua Stern
-
Scott Maloney shared thisThis is a great event. Industry movers, new companies, big companies, investors, and more. Come for the speakers and this sweet opportunity to present your company (link below), and stay because I’ll buy you a drink and want to hear about your plans for growth. The 2026 Animal Health Summit showcases pharmaceutical, vaccine, nutrition, diagnostic and technology companies from throughout the world. We are seeking companies serving the companion animal health, ag-tech, and/or food animal production segments; seeking $500,000 to $20 million in funding OR strategic partnerships to advance a company’s technology; and have revenue projections of $20 million within five to seven years. #AHSummit26 #Innovation #Startups #Investment #VentureCapital #AnimalHealth Apply now, https://shorturl.at/P559G.
-
Scott Maloney posted thisNext week I’ll be at WVC in Las Vegas. I’m popping in fast for a few pretty big meetings that will be announced soon, so if you see me power-walking with my head down, apologies in advance. What I’m genuinely excited to see (between sprint intervals): the AI stuff that is finally moving past chatbots and properly into workflows. The new diagnostics that are quietly turning clinics into miniature data factories. And the biologic therapeutics wave that keeps accelerating and grabbing at the future of medicine. And, yes, it’s happening in Vegas, because nothing says “serious science” like tacky convention hall carpet and a 6 a.m. coffee that tastes like it was made three days prior. See you soon. #WVC2026 #VeterinaryMedicine #VetMed #AnimalHealth #CompanionAnimalHealth #VetTech #VeterinaryInnovation #VetInnovation #HealthTech #VentureCapital #Startups
-
Scott Maloney posted thisI am just back from VMX and it is clear to me that we are in the middle of the next great era in veterinary care. Clinic 1.0: the neighborhood general practice. The purest form of the profession. Grit, trust, continuity, and medicine that was often better than the systems surrounding it. These clinics built the bond with pet owners and carried the industry on their backs. Clinic 2.0: the modernization wave. Real operations. Better client communication. Better scheduling. Better inventory discipline. Tech stacks that don’t look like a junk drawer. Sometimes corporate, sometimes just a strong operator who decided chaos is not a personality trait. 2.0 didn’t “sell out.” It professionalized. Now we’re told the next step is… more 2.0??? Slightly nicer waiting rooms. Slightly cleaner SOPs. Slightly more dashboards. Slightly more “synergy.” Cute, but not meaningful. Here’s the actual next wave: Clinic 3.0 is speciation. Single-species practices that keep the operational sophistication of 2.0, while finally admitting the obvious: cats and dogs are not the same patient, experience, or workflow. Running them under one roof is like claiming you “specialize in humans,” and then treating toddlers, triathletes, and grandparents in the same room with the same process. Speciation is not boutique. It’s focus. Focus is how you get: --better medicine through repetition and deep expertise --calmer visits because the environment is designed for one species' reality --tighter scheduling because you stop treating a stressed cat like an afterthought between two anxious doodles --less inventory bloat because you’re not stocking two different worlds --clearer culture and a sharper brand because the mission is coherent General practice will always be the backbone. But the clinics that win the next decade won’t be the ones trying to be everything to everyone. They’ll be the ones built to be excellent for someone specific. 1.0 built trust. 2.0 built professionalism. 3.0 will build precision. #veterinarymedicine #animalhealth #petcare #healthcareinnovation #clinicoperations #customerexperience #strategy Craig S. Wallace Kristin Wuhrman Jason Epstein Alex Emerson
-
Scott Maloney liked thisGreat visit this week at the MWI Animal Health Amarillo office to meet with our production animal leadership team and colleagues from Zoetis. Conversations like these are a reminder of what partnership is really about — sitting down together, being honest about where the industry stands, and finding new ways to create value for the customers we both serve. Our industry has its share of challenges right now, but time with this group of leaders makes me genuinely energized about what’s possible! Thank you to the Zoetis team for making the trip to Amarillo. Looking forward to what we build next. Jim Niple Abhay Nayak
-
Scott Maloney liked thisScott Maloney liked thisLooking forward to seeing friends and supporters on September 12th at our Open House in #Aurora #Colorado!!! Let's goooo!!! #cats #veterinarymedicine #animalhealth #entrepreneurs Kristin Wuhrman Alex Emerson Jason Epstein Scott Maloney Courtney Schauer Alley Flood CatsOnly.vet
-
Scott Maloney liked thisSuper proud and super pumped!🐱 CatsOnly.vet Stanley Marketplace is almost here 🌟 Grand Opening is September 21! We opened up appointments just one week ago, and the response from Denver Cat Parents has been incredible 😻 Scott Maloney Jason Epstein Alex Emerson Craig S. Wallace Alley Flood Courtney Schauer Gina Fortunato, MBA Jane Brunt Jon Ayers Heather O'Steen, CAE Anne Fundakowski Tanya Cooper, MBA, Elite FFCP-V David Dieffenbach Joey Goldthorpe Ken Lambrecht Florian Radke Séverine Tasker Ellen Carozza LVT, RVT, VTS(CP-Feline) Feline Veterinary Medical Association Fear Free, LLCScott Maloney liked thisHospital construction update! We are a few weeks away - Grand Opening is September 21st! 💫😻 #CatsOnly #FelineMedicine #Cats #CatsMatter #CatParents Kristin Wuhrman Scott Maloney Jason Epstein Craig S. Wallace Alley Flood Alex Emerson Courtney Schauer Ellen Carozza LVT, RVT, VTS(CP-Feline) Joshua Stern Mikel Delgado, PhD
-
Scott Maloney liked thisScott Maloney liked thisHospital construction update! We are a few weeks away - Grand Opening is September 21st! 💫😻 #CatsOnly #FelineMedicine #Cats #CatsMatter #CatParents Kristin Wuhrman Scott Maloney Jason Epstein Craig S. Wallace Alley Flood Alex Emerson Courtney Schauer Ellen Carozza LVT, RVT, VTS(CP-Feline) Joshua Stern Mikel Delgado, PhD
-
Scott Maloney liked thisScott Maloney liked thisGreat to know NVG Board Member Nate Weis with this great Q&A by the Napa Valley Register. Click through and find out why Nate's dream of becoming a jet pilot didn't quite work out. https://lnkd.in/gNGSTVmbHow Nate Weis blends tradition and innovation at bvwinesHow Nate Weis blends tradition and innovation at bvwines
-
Scott Maloney liked thisScott Maloney liked thisValues matter most when other people can see them in the way we work. Congratulations to my University Advancement colleague Christie Cotterill, who was recently recognized with a Seattle University values award. What stood out to me the most about the recognition was how concrete and consistent nominators were in naming the ways in which Christie lives our shared values in her work. She was nominated for building relationships, asking thoughtful questions, creating clarity of purpose, maintaining high standards, and, perhaps most importantly, supporting colleagues and community members with respect and care. She brings people together around ambitious goals and then helps move our shared work forward. Those are values made visible through action. Congratulations, Christie, on a very well-deserved recognition! Seattle University is better because of the way you lead, the way you support our common purpose, and the way you work. #SeattleUniversity #PrincipledLeadership #ValuesInAction
-
Scott Maloney liked thisScott Maloney liked thisIt’s week two of training for our inaugural CatsOnly.vet clinical team! Ellen Carozza LVT, RVT, VTS(CP-Feline) is leading this week’s feline-specific training, with Stubs serving as a very capable assistant. 🐱 And Stubs approves of the new sign too! #CatsOnly #FelineMedicine #CatsMatter #Cats #FelineTraining Kristin Wuhrman Alley Flood Jason Epstein Scott Maloney Courtney Schauer Alex Emerson Craig S. Wallace
Experience & Education
Volunteer Experience
-
Member, Board of Directors
Indiana University - Kelley School of Business
- 3 years 1 month
Education
Board of Directors for the Kelley School of Business, a leading global Top 20 business school.
-
Trustee
Washington State University
- 5 years
Education
Washington State University Foundation Trustee. Provide support and thought leadership to broad reaching university activities impacting financial resources, operations, and leadership.
-
Guest Lecturer, Keynote Speaker, Panelist
Invited Speaker
- Present 16 years 5 months
Invited Key Note conference speaker on The Business of Life Sciences, Technology Development, Innovation Culture, Strategic Operations, Startups, Product Strategy, and others.
Panelist and speaker at numerous national and international conferences on technology, science, and business.
Invited guest lecturer to numerous undergraduate and MBA level courses at several universities as an industry expert on Innovation Management, Operations and Strategic Execution, Product Development,…Invited Key Note conference speaker on The Business of Life Sciences, Technology Development, Innovation Culture, Strategic Operations, Startups, Product Strategy, and others.
Panelist and speaker at numerous national and international conferences on technology, science, and business.
Invited guest lecturer to numerous undergraduate and MBA level courses at several universities as an industry expert on Innovation Management, Operations and Strategic Execution, Product Development, Novel Business Models and Environments, and Entrepreneurship.
-
Finalist Judge and Awarding Judge
The Stevie Awards
- Present 13 years
Economic Empowerment
Finalist round judge and awarding judge for the 2013 Stevie Awards. The Stevie Awards for Women in Business are the world's premier awards for women executives, entrepreneurs, and the organizations they run.
-
Board of Advisors - Professional Science Masters Program
Washington State University
- Present 10 years
Education
The Professional Science Master’s (PSM) at Washington State University is an interdisciplinary graduate degree designed to help students transition into the workplace by training them in skills that employers need. The PSM combines science with training in ethics, business, management, and communication, bridging the gap between academia and the workplace.
http://www.smb.wsu.edu/academic-training/graduate-studies/professional-science-master's-degree -
Panelist at Annual Mayor's Conference
Kauffman Foundation
- 1 month
Economic Empowerment
Invited panelist to speak about capital, investing, startups, and entrepreneurship at the Annual Mayor's Conference. The conference is regularly attended by mayors and mayoral economic development staff from over 40 major US cities.
-
Event Emcee
The National Institutes of Health
- 1 month
Requested Emcee for international NIH conference.
-
Startup Company Mentor and Coach
ABQid, Inc.
- 4 months
ABQid is an Accelerator in Southwest US focused on training and growing the next generation of founders and startup companies. Participants work for three months to grow their companies with the goal of showcasing their product at demo day.
I am a mentor and company coach responsible for providing experience, training, strategic planning and oversight, as well as guidance to companies during the process. -
Invited Speaker
Global Innovation Network for Entrepreneurship and Technology
- Present 12 years 5 months
The Global Innovation Network of Entrepreneurship and Technology, is focused on bringing innovations to the marketplace by creating a global network of programs through collaboration among Academia, Industry, Research & Development Centers, Governments, Investors and Mentors, Multilateral Organizations, and Individuals Visionaries and Entrepreneurs (serial and first time). Our immediate objective is to accelerate the rate of bringing innovative ideas, services, applications, prototypes, and…
The Global Innovation Network of Entrepreneurship and Technology, is focused on bringing innovations to the marketplace by creating a global network of programs through collaboration among Academia, Industry, Research & Development Centers, Governments, Investors and Mentors, Multilateral Organizations, and Individuals Visionaries and Entrepreneurs (serial and first time). Our immediate objective is to accelerate the rate of bringing innovative ideas, services, applications, prototypes, and products through strategic alliances to key investors, industry and government agencies and to bring these innovations to the marketplace.
-
Featured Event Speaker
Startup Weekend
- 1 month
Featured event speaker.
Startup Weekend is a global grassroots movement of active and empowered entrepreneurs who are learning the basics of founding startups and launching successful ventures. It is the largest community of passionate entrepreneurs with over 1800 past events in 120 countries around the world in 2014. -
Official Judge
Startup Weekend
- 1 month
Economic Empowerment
Teen Startup Weekend competition. Event focuses on empowering youth to tap their internal entrepreneur and create a business. Responsible for final judging and evaluating businesses as well as coaching of teams to next steps for developing their company.
-
Official Judge
Startup Weekend
- 1 month
Science and Technology
Judge of Startup Weekend competition. Responsible for evaluating competitor company's business strategy, market planning, financial forecasts, and overall path to success.
Honors & Awards
-
Titan100
TitanCEO
One of only a few business leaders to be awarded two consecutive years in a row.
The Titan100 is a program to recognize a premier group of 100 CEO’s and C-level executives. Representing both the private and public sector, these leaders are Titans of industry who demonstrate exceptional leadership, vision, passion, and influence in their field. -
Titan100
TitanCEO
The Titan100 is a program to recognize a premier group of 100 CEO’s and C-level executives. Representing both the private and public sector, these leaders are Titans of industry who demonstrate exceptional leadership, vision, passion, and influence in their field.
Recommendations received
34 people have recommended Scott
Join now to viewOther similar profiles
Explore more posts
-
David Bearss
Excited to Present at the 2nd Innovation in Obesity Therapeutics Summit Today I’ll be speaking on a topic that represents a major leap forward in how we think about obesity, inflammation, and metabolic health: Reprogramming Immunometabolism: Ofirnoflast & GLP-1 Synergy in the Next Generation of Obesity Therapies For decades, obesity has been treated primarily as a problem of appetite and energy balance. But we now understand that chronic inflammation inside adipose tissue is a major driver of weight gain, insulin resistance, and metabolic disease. At Halia Therapeutics, we’re taking a fundamentally new approach by pairing GLP-1 receptor agonists with Ofirnoflast, our oral allosteric inhibitor of the NEK7-NLRP3 inflammasome. What I’ll Be Sharing Today: • A Dual-Targeted Strategy Uniting semaglutide’s metabolic effects with Ofirnoflast’s direct shutdown of the NEK7-NLRP3 inflammasome tackles both appetite regulation and the inflammatory biology driving obesity. • True Synergy in Preclinical Studies The combination delivers greater weight loss, stronger glycemic control, and deeper suppression of inflammatory markers than either agent alone. • Beyond Weight Loss By reversing adipose tissue dysfunction and reducing inflammatory stress, this approach may help: – Preserve β-cell function – Improve metabolic flexibility – Protect the heart, liver, and kidneys from inflammation-driven injury This is about more than losing weight—it’s about changing the underlying disease biology. It’s an exciting time for metabolic therapeutics, and I’m grateful to be part of a community pushing the boundaries of what’s possible.
2 Comments -
Bo wtiedBiotech
Signals That Sell | Ep. 849 Biotech VC is brutal. LPs fund proof, not potential. Today we have a metrics-first playbook for raising your next fund, returning cash, and compounding credibility. Presenting: 10 signals LPs actually underwrite 👇 1⃣ DPI over TVPI 2️⃣ Top-quartile, credible TVPI 3️⃣ Crossover & pharma magnetism 4️⃣ Winner concentration 5️⃣ Capital efficiency 6️⃣ Syndicate quality 7️⃣ Ownership at inflection 8️⃣ Exit line of sight 9️⃣ Thematic edge 🔟 Fund construction If you are raising $$$, or plan to, this is for you. Subscribe here: https://lnkd.in/eMN_Hgjv
-
Kit Yu
We see the SMID Cap biotech sector at an inflection point as ~36% (31/86 companies) of our coverage is poised to potentially make the transition from being a "SMID Cap" to becoming a "Big Cap" company. To understand this, we note three key differences between SMID Cap and Big Cap companies in the biotech/biopharma universe (Exhibit 5): 1) Key product exposure - large cap companies tend to have more diverse revenue streams; ii) R&D Pipeline Programs - large cap names have larger pipelines; and 3) Balance Sheet capacity - large cap companies have ample balance sheet capacity.
-
Enke Bashllari, Ph.D.
Yesterday Nabla Bio announced a up to $1B deal with Takeda signaling to the pharma industry: AI is no longer a nice to have, it's core infrastructure. Why this matters: 👇 - Historically, pharma has been cautious to bet big on AI in drug discovery. That hesitation has led to a wave of point solutions that predict, screen, or optimize a single step of the R&D process yielding almost insignificant value creation for AI x drug discovery startups. - Nabla’s deal hints at a bigger shift in the market, one where pharma moves from funding experimental pilots, or adopting point solutions, to forming integrated partnerships with significant upside for AI x drug discovery startups. - If this collaboration delivers, it's the business model we have been sorely missing. It could become the playbook for AI in drug discovery startups that want to build lasting businesses. Combined with AstraZeneca's $555 million bet earlier this month with Algen Biotechnologies to use machine learning for immunology targets, and Eli Lilly and Company up to $1.3B deal with Superluminal Medicines for its small molecule AI capabilities, this signals a clear shift towards real integration of AI-native drug development. Exciting times. #AIDrugDiscovery #Biotech #Pharma #GenerativeBiology #FoundationModels #DrugDevelopment Image credit: Biospace, article in comments
4 Comments
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top contentOthers named Scott Maloney in United States
68 others named Scott Maloney in United States are on LinkedIn
See others named Scott Maloney